Gynecologic Oncology Program at NYU Winthrop Hospital Center for Cancer Care
The Gynecologic Oncology Program at NYU Winthrop Hospital is one of the most comprehensive centers of its kind in the region. We are committed to excellent patient care and coordinated multidisciplinary treatment.
The team includes board certified gynecologic oncologists, pathologists, radiologists, radiation oncologists and medical oncologists, as well as exceptionally trained and experienced physician assistants, nurses, navigators and a compassionate support staff that offers extensive services required to provide superior care.
The team members collaborate to provide accurate diagnoses, create highly individualized treatment plans. We offer leading-edge radical and ultra-radical surgical procedures, standard and innovative methods of radiation therapy and chemotherapy.
The combination of expertise and access to appropriate resources results in aggressive, state-of-the-art care aimed at attaining the best possible clinical outcomes. Comprehensive care also includes:
- Genetic and nutritional counseling
- Financial support services
- Social services
- Pastoral support
- Cancer support groups
- Palliative care
NYU Winthrop is also the first satellite site of the Gilda Radner Familial Ovarian Cancer Registry.
Leaders in Gynecologic Oncology Care
As leaders in gynecologic cancer care and research, our board-certified team of specialists work in close coordination with medical oncology, pathology, oncology nursing, radiation oncology, surgical oncology, cancer genetics and social services to provide treatment for all related cancers and pre-cancers.
Gynecologic Oncology Conditions We Treat
- Uterine Cancer
- Ovarian and Peritoneal Cancers
- Cervical Cancer
- Fallopian Tube Cancer
- Cancers of the Vagina and Vulva
- Premalignant Conditions of the Vulva, Vagina, Cervix and Uterus
- Risk-reducing Surgery
- Complex Gynecologic Conditions
Cutting Edge Research and Clinical Trials
The team at NYU Winthrop’s Gynecologic Oncology Program actively participates in clinical research trials supported by the National Cancer Institute (NCI) through the Gynecologic Oncology Group and multiple industry trials sponsored by major pharmaceutical companies, affording patients access to the newest chemotherapeutic agents.
Our physicians are recognized leaders in major national organizations, contributing to improvement in patient care through presentation on clinical and translational research, service on committees and active fundraising aimed at helping these organizations achieve their mission. They also participate in patient advocate activities regionally and nationally.
Available treatment options include the latest in surgical, minimally-invasive, chemotherapeutic and biologic therapies such as: